Based on the detection of increased tumor-infiltrating CD8+ T cells in ALK5ΔCD8 and LY-treated mice, we hypothesized that TGFβ may inhibit either in situ proliferation or tumor trafficking of CD8+ T cells, or both. The gene discussed is TGFB1; the disease is neoplasm.